#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lennox-Gastaut syndrome Glomerulonephritis acute Sarcoidosis Deafness bilateral Malignant central nervous system neoplasm Dermatitis Pituitary-dependent Cushing's syndrome Endometrial adenocarcinoma Loss of consciousness Drug eruption Retinitis pigmentosa Pancreatic carcinoma metastatic Cutaneous T-cell lymphoma stage II Subdural haematoma Pleural mesothelioma More trials…

    Learn about Rare Diseases

    Breast angiosarcoma metastatic – Diagnostics Lymphangioma Glycogen storage disease type V – Basic Information Synovial sarcoma – Trials in Disease Immunodeficiency congenital – Trials in Disease Angiosarcoma non-metastatic – Diagnostics Encephalitis autoimmune – Diagnostics Angiosarcoma non-metastatic – Trials in Disease Langerhans cell sarcoma Haemolytic uraemic syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tozorakimab Pasireotide Gabapentin Donanemab Oms906 PROMESTRIENE MAPLIRPACEPT Ferric Derisomaltose Deferoxamine Tecaginlimab Art0380 Mesilate Clonidine Hydrochloride Collagenase Balstilimab Galunisertib Trimetazidine Dihydrochloride Relugolix Tipiracil Triptorelin Dorzolamide More therapies…

    Learn about Your Condition

    Neoplasm Gallbladder cancer Nephrolithiasis Erythema Rabies Leukaemia Right ventricular dysfunction Osteomyelitis acute Shock Neonatal hyperglycaemia Hypereosinophilic syndrome Breast cancer male Tonsillitis Epiphysiolysis Deafness neurosensory More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bulgaria

  • Study of mirikizumab and tirzepatide for adults with moderate to severe Crohn’s disease who are overweight or obese

    Recruiting

    3 1
    Investigated Drugs:
    • Mirikizumab
    • Tirzepatide
    Austria Belgium Bulgaria Czechia Denmark France +9
  • Study of MK-1084 and Pembrolizumab for First-Line Treatment in Patients with Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation and High PD-L1 Levels

    Recruiting

    3 1 1
    Investigated Drugs:
    • Mk-1084
    • Pembrolizumab
    Austria Bulgaria France Germany Greece Italy +4
  • Efficacy and safety of oral semaglutide for weight loss in adults with overweight or obesity

    Recruiting

    3 1 1
    Investigated Drugs:
    • Semaglutide
    Belgium Bulgaria Denmark France Greece The Netherlands +3
  • Efficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations

    Recruiting

    3 1 1
    Investigated Drugs:
    • Depemokimab
    Belgium Bulgaria Czechia France Germany Ireland +3
  • A Phase 3 Study of Enpatoran to Treat Active Cutaneous Lupus in Patients With or Without Systemic Disease

    Recruiting

    3 1
    Investigated Diseases:
    • Chronic cutaneous lupus erythematosus
    • Cutaneous lupus erythematosus
    • Subacute cutaneous lupus erythematosus
    Belgium Bulgaria Czechia France Germany Greece +4
  • A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis

    Recruiting

    3 1
    Austria Belgium Bulgaria Croatia Czechia Denmark +15
1 2 3 … 135
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Pembrolizumab Carboplatin Cisplatin Dexamethasone Semaglutide Upadacitinib Sodium Chloride Prednisone Dapagliflozin Pemetrexed Mycophenolate Mofetil Efgartigimod Alfa Rituximab Fulvestrant Trospium Chloride Salbutamol Paclitaxel Xanomeline Tartrate Prednisolone Ruxolitinib Risankizumab Paracetamol Zasocitinib Guselkumab Ocrelizumab Methylprednisolone Formoterol Fumarate Dihydrate Glycopyrronium Bromide Durvalumab Letrozole Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Abdominal infection Acquired ATTR amyloidosis Acquired C1 inhibitor deficiency Acromegaly Acute coronary syndrome Acute haemorrhagic ulcerative colitis Acute hepatic failure Acute lymphocytic leukaemia Acute myeloid leukaemia Acute myocardial infarction Acute respiratory distress syndrome Acute respiratory failure Adenomyosis Adrenogenital syndrome Alcoholic liver disease Alopecia areata Anaemia Anaemia of chronic disease Anal incontinence Angina pectoris Anhedonia Ankylosing spondylitis Arteriosclerosis Arteriovenous graft thrombosis Asthma Asthmatic crisis Atrial fibrillation Axial spondyloarthritis B-cell lymphoma B-cell small lymphocytic lymphoma Bacterial infection Bipolar disorder Bipolar I disorder Bladder cancer Breast cancer Breast cancer metastatic Bronchiectasis Cachexia Cardiac ablation Cardiac amyloidosis Cardiac failure Cardiac failure chronic Cardiovascular disorder Central nervous system melanoma Cerebrovascular accident prophylaxis Cervix carcinoma recurrent Cholangiocarcinoma Cholestatic pruritus Chronic cutaneous lupus erythematosus Chronic hepatitis Chronic hepatitis B Chronic inflammatory demyelinating polyradiculoneuropathy Chronic kidney disease Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia recurrent Chronic myeloid leukaemia Chronic myelomonocytic leukaemia Chronic obstructive pulmonary disease Chronic rhinosinusitis with nasal polyps Chronic sinusitis Chronic spontaneous urticaria Clear cell renal cell carcinoma Clostridium difficile infection Coagulation factor X level Cognitive disorder Cold urticaria Colitis ulcerative Colorectal adenocarcinoma Colorectal cancer Colorectal cancer metastatic Conjunctivitis allergic Connective tissue disorder Constipation COVID-19 Crohn's disease Cushing's syndrome Cutaneous lupus erythematosus Deep vein thrombosis Dementia Alzheimer's type Dementia of the Alzheimer's type with delusions Dementia with Lewy bodies Dermatitis Dermatitis atopic Dermatomyositis Diabetic foot infection Diabetic neuropathy Diabetic retinal oedema Diffuse large B-cell lymphoma Dilated cardiomyopathy Dry age-related macular degeneration Dry eye Duchenne muscular dystrophy Dyslipidaemia Eczema nummular EGFR gene mutation Embolism Embolism venous Endocrine ophthalmopathy Endometrial adenocarcinoma Endometrial cancer Endometriosis Epilepsy Epstein-Barr virus associated lymphoma Erosive oesophagitis Ex-tobacco user Eyelid ptosis Factor IX deficiency Factor VIII deficiency Fallopian tube cancer Familial hypertriglyceridaemia Follicle centre lymphoma follicular grade I, II - III Follicular lymphoma Gastric cancer Gastrointestinal cancer metastatic Gastrointestinal melanoma Gastrooesophageal reflux disease Generalised anxiety disorder Generalised tonic-clonic seizure Genital herpes simplex Gout Haematological infection Haemophilia A with anti factor VIII Haemophilia A without inhibitors Haemophilia B without inhibitors Hepatic cirrhosis Hepatic encephalopathy Hepatitis B Hepatitis D Hepatitis viral Hepatocellular carcinoma HER2 positive breast cancer Hereditary angioedema Hereditary angioedema with C1 esterase inhibitor deficiency Hereditary neuropathic amyloidosis Hidradenitis High-grade B-cell lymphoma Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-dependent prostate cancer Hormone-refractory prostate cancer Huntington's disease Hypercholesterolaemia Hyperchylomicronaemia Hyperinsulinaemic hypoglycaemia Hyperinsulinism Hyperparathyroidism secondary Hypertension Hypertriglyceridaemia Hypertrophic cardiomyopathy Idiopathic inflammatory myopathy Idiopathic pulmonary fibrosis IgA nephropathy Immune thrombocytopenia Inborn error of metabolism Indolent systemic mastocytosis Infection prophylaxis Influenza Influenza immunisation Insomnia Iridocyclitis Iron deficiency Ischaemic stroke Juvenile idiopathic arthritis Left ventricular dysfunction Lung adenocarcinoma Lupus nephritis Macular oedema Magnetic resonance imaging Major depression Malignant melanoma Malignant melanoma of eyelid Malignant melanoma stage III Malignant melanoma stage IV Mania Marginal zone lymphoma Melanoma recurrent Metabolic dysfunction-associated liver disease Metabolic dysfunction-associated steatohepatitis Metapneumovirus infection Metastatic malignant melanoma Migraine Multiple sclerosis Multiple sclerosis relapse Muscle spasticity Myasthenia gravis Myelodysplastic syndrome Myelofibrosis Myeloproliferative neoplasm Neoplasm Neoplasm malignant Neovascular age-related macular degeneration Nephrogenic anaemia Nervous system disorder Netherton's syndrome Neuralgia Neurodermatitis Neuroendocrine carcinoma Neuropathy peripheral Non-alcoholic steatohepatitis Non-Hodgkin's lymphoma Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer recurrent Non-small cell lung cancer stage III Non-small cell lung cancer stage IIIA Non-small cell lung cancer stage IIIB Non-small cell lung cancer stage IV Noonan syndrome Obesity Open angle glaucoma Osteoarthritis Osteoporosis Osteoporosis postmenopausal Ovarian cancer Ovarian epithelial cancer Overweight Pain Pancreatic carcinoma metastatic Pancreatic failure Paranasal sinus inflammation Parkinson's disease Partial seizures Pemphigoid Philadelphia positive acute lymphocytic leukaemia Pituitary-dependent Cushing's syndrome Plasma cell myeloma Pneumonia Polycythaemia vera Polymyositis Porphyria non-acute Post herpetic neuralgia Postoperative analgesia Pre-eclampsia Primary biliary cholangitis Primary myelofibrosis Primary progressive multiple sclerosis Progressive multiple sclerosis Progressive relapsing multiple sclerosis Progressive supranuclear palsy Prostate cancer Prostate cancer metastatic Proteinuria Psoriasis Psoriatic arthropathy Psychotic disorder Pulmonary arterial hypertension Pulmonary hypertension Pyelonephritis acute Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Renal cell carcinoma Respiratory syncytial virus infection Retinal vein occlusion Retinopathy of prematurity Rheumatoid arthritis Rhinitis allergic Schizophrenia Secondary progressive multiple sclerosis Seizure Sepsis Short stature Sinusitis noninfective Sjogren's syndrome Skin bacterial infection Small cell lung cancer Small cell lung cancer extensive stage Small cell lung cancer limited stage Small cell lung cancer recurrent Small for dates baby Squamous cell carcinoma of head and neck Squamous cell carcinoma of lung Squamous cell carcinoma of skin Still's disease Subacute cutaneous lupus erythematosus Systemic candida Systemic lupus erythematosus Systemic scleroderma Thalassaemia Thrombocytopenia Thrombolysis Thrombosis prophylaxis Tourette's disorder Transient ischaemic attack Transitional cell cancer of the renal pelvis and ureter Transitional cell carcinoma Triple negative breast cancer Turner's syndrome Type 2 diabetes mellitus Type IIa hyperlipidaemia Urea cycle disorder Urinary tract infection Varicella Vernal keratoconjunctivitis Vitiligo Warm autoimmune haemolytic anaemia

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!